Trupanion, Inc. (Nasdaq: TRUP), a leader in medical insurance for cats and dogs, announced today that Fawwad Qureshi, Chief Financial Officer, will present at the 46th Annual Raymond James ...
With a rising number of pet owners and increased spending, the pet industry is demonstrating strong growth potential.
Research analysts at William Blair cut their Q1 2025 EPS estimates for Trupanion in a note issued to investors on Thursday, ...
Trupanion (NASDAQ:TRUP – Free Report) had its target price trimmed by Piper Sandler from $57.00 to $52.00 in a research ...
5d
Zacks.com on MSNAfter Plunging -26.69% in 4 Weeks, Here's Why the Trend Might Reverse for Trupanion (TRUP)A downtrend has been apparent in Trupanion (TRUP) lately with too much selling pressure. The stock has declined 26.7% over ...
Bank of America Securities analyst Joshua Shanker maintained a Buy rating on Trupanion (TRUP – Research Report) today. The company’s shares ...
Lake Street analyst Ryan Meyers maintained a Buy rating on Trupanion (TRUP – Research Report) today and set a price target of $65.00. The ...
Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results ...
Trupanion, Inc.’s TRUP share price has dipped by 25.49%, which has investors questioning if this is right time to buy.
7d
Hosted on MSNTrupanion (TRUP) Q4 Earnings Lag EstimatesTrupanion (TRUP) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to loss of $0.05 per share a year ago. These figures are ...
Although the revenue and EPS for Trupanion (TRUP) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results